Elevated Tumor Necrosis Factor-αSuppresses TAZ Expression and Impairs Osteogenic Potential of Flk-1+Mesenchymal Stem Cells in Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

Elevated Tumor Necrosis Factor-αSuppresses TAZ Expression and Impairs Osteogenic Potential of Flk-1+Mesenchymal Stem Cells in Patients with Multiple Myeloma

Published:2007-12 Issue:6 Volume:16 Page:921-930
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Li Bingzong¹²³,Shi Mingxia¹⁴³,Li Jing¹,Zhang Hongbing¹,Chen Bin¹,Chen Lei⁵,Gao Weibo¹,Giuliani Nicola⁶,Zhao Robert Chunhua¹⁵

Affiliation:

1. Institute of Basic Medical Sciences and School of Basic Medicine, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China.

2. Department of Hematology, Second Affiliated Hospital of Soochow University, Suzhou, P.R. China.

3. Bingzong Li and Mingxia Shi contributed equally to this study.

4. Department of Hematology, First Affiliated Hospital of Kunming Medical College, Kunming, P.R. China.

5. State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R. China.

6. Laboratory of Hematology, Hematology and BMT Center, Department of Internal Medicine and Biomedical Science, University of Parma, Parma, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2007.0074

Reference34 articles.

1. New Insights in Myeloma-induced Osteolysis

2. Multiple Myeloma

3. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease.

4. BONE DISEASE IN MULTIPLE MYELOMA

5. Myeloma bone disease

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease;Leukemia;2024-02-17

2. Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.;2023-06-30

3. Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents;Journal of Bone and Mineral Metabolism;2023-03-01

4. Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again;Hematology Reports;2023-01-09

5. Consequences of Aging on Bone;Aging and disease;2023